Inhibikase Therapeutics Inc (IKT)
2.13
0.00 (0.00%)
USD |
NASDAQ |
Apr 17, 16:00
2.14
+0.01
(+0.47%)
After-Hours: 20:00
Inhibikase Therapeutics Price to Book Value: 1.274 for April 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 17, 2024 | 1.274 |
| April 16, 2024 | 1.272 |
| April 15, 2024 | 1.313 |
| April 12, 2024 | 1.31 |
| April 11, 2024 | 1.346 |
| April 10, 2024 | 1.286 |
| April 09, 2024 | 1.274 |
| April 08, 2024 | 1.322 |
| April 05, 2024 | 1.316 |
| April 04, 2024 | 1.316 |
| April 03, 2024 | 1.286 |
| April 02, 2024 | 1.286 |
| April 01, 2024 | 1.292 |
| March 28, 2024 | 1.274 |
| March 27, 2024 | 1.357 |
| March 26, 2024 | 1.351 |
| March 25, 2024 | 1.304 |
| March 22, 2024 | 1.316 |
| March 21, 2024 | 1.304 |
| March 20, 2024 | 1.210 |
| March 19, 2024 | 1.139 |
| March 18, 2024 | 1.186 |
| March 15, 2024 | 1.245 |
| March 14, 2024 | 1.257 |
| March 13, 2024 | 1.316 |
| Date | Value |
|---|---|
| March 12, 2024 | 1.339 |
| March 11, 2024 | 1.434 |
| March 08, 2024 | 1.457 |
| March 07, 2024 | 1.428 |
| March 06, 2024 | 1.422 |
| March 05, 2024 | 1.404 |
| March 04, 2024 | 1.328 |
| March 01, 2024 | 1.268 |
| February 29, 2024 | 1.217 |
| February 28, 2024 | 1.251 |
| February 27, 2024 | 1.274 |
| February 26, 2024 | 1.251 |
| February 23, 2024 | 1.206 |
| February 22, 2024 | 1.228 |
| February 21, 2024 | 1.251 |
| February 20, 2024 | 1.285 |
| February 16, 2024 | 1.330 |
| February 15, 2024 | 1.336 |
| February 14, 2024 | 1.431 |
| February 13, 2024 | 1.392 |
| February 12, 2024 | 1.443 |
| February 09, 2024 | 1.510 |
| February 08, 2024 | 1.550 |
| February 07, 2024 | 1.533 |
| February 06, 2024 | 1.679 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2775
Minimum
Sep 19 2023
9.538
Maximum
Jun 24 2021
1.761
Average
0.8832
Median
Oct 07 2022
Price to Book Value Benchmarks
| Tenax Therapeutics Inc | 0.8681 |
| BioRestorative Therapies Inc | 0.8158 |
| ADMA Biologics Inc | 10.20 |
| Corbus Pharmaceuticals Holdings Inc | -- |
| Equillium Inc | 2.827 |
Price to Book Value Related Metrics
| Price | 2.13 |
| Earnings Yield | -167.6% |
| Market Cap | 13.99M |